Years of exposure | Current exposure | |||||
---|---|---|---|---|---|---|
Lung function | R2 | β Adjusted | R2 | β Category I | β Category II | β Category III |
*p<0.05; **p<0.01. | ||||||
FEV1 (l): | ||||||
Men | 0.341 | −0.199* | 0.353 | 0.079 | 0.177** | 0.177* |
Women | 0.248 | −0.042 | 0.262 | NS | NS | NS |
FVC (l): | ||||||
Men | 0.296 | −0.115** | 0.315 | 0.05 | 0.134 | 0.127 |
Women | 0.127 | 0.02 | 0.140 | 0.153 | 0.132 | 0.076 |
FEV1/FVC (%): | ||||||
Men | 0.058 | −0.140** | 0.068 | 0.07 | 0.138 | 0.119 |
Women | 0.087 | −0.073 | 0.100 | −0.09 | −0.01 | −0.03 |
MEF (l/s): | ||||||
Men | 0.083 | −0.141** | 0.090 | 0.028 | 0.095 | 0.050 |
Women | 0.055 | −0.012 | 0.073 | 0.167 | 0.195 | 0.170 |
PEF (l/s): | ||||||
Men | 0.121 | −0.080 | 0.125 | 0.219** | 0.191 | 0.143 |
Women | 0.063 | 0.022 | 0.097 | 0.290** | 0.256** | 0.234* |
Resonance frequency: | ||||||
Men | 0.068 | 0.053 | 0.099 | −0.505* | −0.538* | −0.416* |
Women | 0.113 | 0.072 | 0.123 | −0.300** | −0.294** | −0.147 |
Average resistance (R): | ||||||
Men | 0.061 | −0.013 | 0.072 | −0.220 | −0.250 | 0.220** |
Women | 0.037 | −0.001 | 0.045 | 0.202 | 0.176 | 0.030 |
Reactance (X): | ||||||
Men | 0.025 | 0.033 | 0.051 | 0.386* | 0.453* | 0.295* |
Women | 0.100 | −0.072 | 0.111 | 0.308** | 0.256 | 0.177** |
Frequency dependence: | ||||||
Men | 0.010 | −0.117 | 0.028 | 0.340** | 0.330** | 0.250** |
Women | 0.029 | −0.059 | 0.041 | 0.020 | 0.030 | 0.040 |